The Centers for Medicare & Medicaid Services yesterday released guidance for state Medicaid agencies implementing Section 5052 of the SUPPORT for Patients and Communities Act of 2018, which gives states the option to cover substance use disorder treatment and withdrawal management services for adults who reside primarily in an eligible institution for mental diseases. The guidance provides information on the new state plan option, including requirements related to beneficiary and provider eligibility, clinical screenings, continuum of care, care transitions, and maintenance of existing expenditures.

Related News Articles

Headline
The House of Representatives today voted 231-192 to approve a continuing resolution that would fund the federal government through Dec. 20 and delay impending…
Headline
The Centers for Medicare…
Headline
The Centers for Medicare…
Headline
The Centers for Medicare…
Headline
The U.S. Court of Appeals for the 8th Circuit this week reversed a district court ruling that permanently barred the Centers for Medicare…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, of which the AHA is a sponsor, yesterday concluded a two-day…